Potential Demand for Antifungal Drugs due to High Prevalence of Mycological Infections around the Globe

In 2017, the global antifungal drugs market size was valued at USD 11.3 billion. Growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propelling the market.

ID: 1557108
recent pressrelease next pressrelease

(businesspress24) - The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 1.5% during the forecast period. Increasing incidence of fungal infections worldwide is the key factor stoking the growth of the market. In addition, rise in adoption of immunosuppressive and antineoplastic agents, prosthetic devices and grafts, and broad-spectrum antibiotics has resulted in increased incidence of fungal infections in recent years.

According to statistics published by the Centers of Disease Control and Prevention in 2017, it has been estimated that every year, nearly 220,000 new individuals are affected by cryptococcal meningitis, which is a brain infection and has resulted in 181,000 deaths per year around the world. Most of the deaths were reported in sub-Saharan Africa, due to high prevalence of HIV/AIDS. This indicates the potential demand for antifungal drugs due to high prevalence of mycological infections around the globe.

As aged people are more prone to infectious diseases and chronic conditions, including HIV and cancer, rise in geriatric population worldwide is likely to stir up the demand for antifungals to treat opportunistic fungal infections. The demand for fungistatic agents is estimated to remain strong through 2025 due to mounting cases of fungal infections that are difficult to diagnose, yielding high mortality and morbidity rates.

Further key findings from the study suggest:
& injections, are available. Increasing adoption of these products is anticipated to drive the market during the forecast period


fungal drug for the treatment of pulmonary aspergillus.



More information:
http://https://tinyurl.com/sz6y87q



Keywords (optional):

antifungal-drugs, antifungal, drugs, medicine, medical, healthcare, health, pharma, pharmaceutical,



Company information / Profile:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

PressRelease by

Requests:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales(at)grandviewresearch.com
For More Information: www.grandviewresearch.com



PressContact / Agency:



published by: HexaResearch
print pressrelease  send to a friend  

Date: 03/26/2020 - 11:11
Language: English
News-ID 1557108
Character count: 3408
Kontakt-Informationen:
Firma: Grand View Research, Inc.
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: San Francisco
Telefon: 1-888-202-9519

Meldungsart: Financial
Versandart: send
Freigabedatum: 26.03.2020
Comments:



Number of hits: 1078

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 72


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.